tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SABS Stock Latest News

SAB Biotherapeutics Approves Equity Plan Amendments
Company AnnouncementsSAB Biotherapeutics Approves Equity Plan Amendments
3d ago
8K
SABS
Promising Developments and Strategic Partnerships Drive Buy Rating for SAB Biotherapeutics’ SAB-142
PremiumRatings
Promising Developments and Strategic Partnerships Drive Buy Rating for SAB Biotherapeutics’ SAB-142
7d ago
SABS
SAB Biotherapeutics highlights data in multiple presentations at EASD
PremiumThe Fly
SAB Biotherapeutics highlights data in multiple presentations at EASD
10d ago
SABS
SAB Biotherapeutics initiated with an Outperform at Leerink
PremiumThe Fly
SAB Biotherapeutics initiated with an Outperform at Leerink
12d ago
SABS
SAB Biotherapeutics files to sell 250M shares of common stock for holders
PremiumThe Fly
SAB Biotherapeutics files to sell 250M shares of common stock for holders
27d ago
SABS
SAB Biotherapeutics price target lowered to $12 from $20 at Chardan
PremiumThe FlySAB Biotherapeutics price target lowered to $12 from $20 at Chardan
2M ago
SABS
SAB Biotherapeutics Reports Increased Losses Amid Funding Boost
Premium
Company Announcements
SAB Biotherapeutics Reports Increased Losses Amid Funding Boost
2M ago
SABS
SAB Biotherapeutics Secures $175M Funding, Paving Way for Phase 2b Diabetes Trial and Justifying Buy Rating
Premium
Ratings
SAB Biotherapeutics Secures $175M Funding, Paving Way for Phase 2b Diabetes Trial and Justifying Buy Rating
2M ago
SABS
SAB Biotherapeutics reports Q2 EPS ($1.09) vs. (79c) last year
PremiumThe Fly
SAB Biotherapeutics reports Q2 EPS ($1.09) vs. (79c) last year
2M ago
SABS
SAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
PremiumRatings
SAB Biotherapeutics Secures $175M Investment, Strengthening Financial Position and Advancing Type 1 Diabetes Treatment
2M ago
SABS
SAB Biotherapeutics Secures $175M in Private Placement
PremiumCompany Announcements
SAB Biotherapeutics Secures $175M in Private Placement
2M ago
8K
SABS
SAB Biotherapeutics announces oversubscribed $175M private placement
PremiumThe Fly
SAB Biotherapeutics announces oversubscribed $175M private placement
2M ago
SABS
SAB Biotherapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsSAB Biotherapeutics Holds Annual Stockholders Meeting
2M ago
8K
SABS
SAB Biotherapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
SAB Biotherapeutics assumed with a Buy at H.C. Wainwright
5M ago
SABS
SAB Biotherapeutics reports Q1 net loss $5.2M vs $5M last year
Premium
The Fly
SAB Biotherapeutics reports Q1 net loss $5.2M vs $5M last year
5M ago
SABS
SAB Biotherapeutics Reports 2024 Financial Results and Advances T1D Therapy
PremiumCompany Announcements
SAB Biotherapeutics Reports 2024 Financial Results and Advances T1D Therapy
6M ago
SABS
SAB Biotherapeutics price target lowered to $20 from $25 at Chardan
PremiumThe Fly
SAB Biotherapeutics price target lowered to $20 from $25 at Chardan
6M ago
SABS
Promising Outlook for SAB Biotherapeutics’ SAB-142: Positive Phase 1 Results and Future Growth Potential Justify Buy Rating
PremiumRatings
Promising Outlook for SAB Biotherapeutics’ SAB-142: Positive Phase 1 Results and Future Growth Potential Justify Buy Rating
6M ago
SABS
SAB Biotherapeutics held cash and equivalents of $20.8 million at end of 2024
PremiumThe Fly
SAB Biotherapeutics held cash and equivalents of $20.8 million at end of 2024
6M ago
SABS
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
8M ago
CRGX
LPTX
SAB Biotherapeutics announces data from Phase 1 trial of SAB-142
Premium
The Fly
SAB Biotherapeutics announces data from Phase 1 trial of SAB-142
8M ago
SABS
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
Premium
Market News
These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts
11M ago
GNLX
SABS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >